Clinical trial
Impact of Breast-Conserving Therapy (BCT) on Recurrence in Patients With Triple-Negative Breast Cancer (TNBC) Compared With Mastectomy
NCT02464774 is registered in ClinicalTrials.gov with Xiaoming Xie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Breast-Conserving Therapy (BCT) on Recurrence in Patients With Triple-Negative Breast Cancer (TNBC) Compared With Mastectomy
- Lead sponsor
- Xiaoming Xie
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2015
- Completion date
- Not reported
- Enrollment
- 464 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer